Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. - Wikidata - wikimedia - TriplyDB

Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.

Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.

http://www.wikidata.org/entity/Q36405766

about

Systems biology of cisplatin resistance: past, present and future Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients.MicroRNAs, DNA Damage Response, and Cancer Treatment Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma.WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.The WEE1 regulators CPEB1 and miR-15b switch from inhibitor to activators at G2/M Non-coding RNAs and cancer.Inhibiting cytoplasmic accumulation of HuR synergizes genotoxic agents in urothelial carcinoma of the bladder.Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes.MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.microRNAs in cardiac development and regeneration.The pivotal role of microRNA-155 in the control of cancer.microRNAs in cancer cell response to ionizing radiation.Targeting the microRNA-regulating DNA damage/repair pathways in cancer.CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.miRNA-15a/16: as tumor suppressors and more.The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality.The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy.The role of microRNA-26a in human cancer progression and clinical application.The role and mechanism of WEE1 on the cisplatin resistance reversal of the HepG2/DDP human hepatic cancer cell line.Noncoding RNAs in Therapeutic Resistance of Cancer.MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta.miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification.miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.Knocking down MiR-15a expression promotes the occurrence and development and induces the EMT of NSCLC cells in vitro.

P2860

Q26863585-A25A650E-DA20-475A-BA88-45BA7A89948B Q27011482-684CF6E6-2FF4-480D-8CF7-E9FD7B94CFAA Q27853174-733C3399-5666-4200-A6AE-5DBA04288871 Q28067062-69A00F28-1C23-4BCE-BD03-8F703E3321A8 Q28087499-1C667526-661F-47C8-94A1-EFF6F80C8A6C Q28829013-2BEA99F8-9200-4256-A9DC-8064100A2737 Q28833606-74B8FA30-97ED-4DA3-9C95-940ACB38FCF0 Q34702270-A8E3DCCA-16B2-4655-B466-788EA1FFB783 Q35832394-5BC3EA36-33EB-4437-B76F-4F83AD0EA04A Q36019903-70C86911-6E67-46A5-B0AA-FC226256B596 Q36094121-84E75ACE-9E21-4424-B6A5-03CE1AAB30FC Q36297939-C770D6BB-083E-47CE-95CD-C5FC0A3609A7 Q36585797-93B16C8A-18AD-4ABA-9C2B-92153E8528F8 Q36838414-03B96287-FBA9-45FE-99C5-5B8067D7BC82 Q37139278-0E027E12-BBA1-4791-8E46-08A265F5BAF0 Q37564392-48CADCA0-A0C7-4FC8-BFFF-70B29CEB4618 Q37594361-8CB685A1-C7A8-487C-9C87-A5F160C01ACA Q37642511-A165CFE4-4E4C-4E93-A0EE-AAFA1D9E3D7D Q38103312-C8D84B0D-48A0-4235-BEFB-D193CDB99E71 Q38152297-D169A9BA-8B99-4120-8FEF-E785DC6D4B34 Q38160950-DD53288D-E663-4285-9250-81F4D50C4DD5 Q38246220-86AE04B9-0B72-446F-8ADE-4FBFF900E0E3 Q38379668-6F1835DB-62D1-482F-BCE8-E98DF4C45EE3 Q38564093-60821BE6-85A5-4244-9404-B10B04D2B449 Q38652190-0E8D1FBF-44D2-4DC0-8238-BE77E63FD67D Q38710597-1A57F645-2DFF-49BD-963D-C981744045E9 Q38796729-7B7FAC08-A26E-4D87-B7C9-216D6D6EDBBA Q38807282-DE006A31-95FF-477B-9D71-193435AABB38 Q38885495-BC81B9ED-B894-43A3-B5C6-C07BCD72D078 Q38940572-8F995EA3-2D2D-46B3-935B-2BF90555A8CA Q38998609-1D43B53B-E29B-4215-8249-7E19080D4170 Q39043647-63E11587-6A91-4C5F-83CB-B152228B3B75 Q39149974-0DC6E54C-85FE-485B-A09B-A1E905411DBE Q41924177-9936C174-11B6-445F-AF78-534D4D1794AA Q49544999-6F196612-7D7A-46EE-A8F4-26F8C36F84D5 Q52952429-F9348EA8-DD96-4F84-A34F-A35E45FB380F Q53125127-FDDB9D1C-32B6-4DBF-956C-117D60728DB5 Q55310508-350049F5-567C-4F65-B324-9F2ECEE07A62

P2860

Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.

http://www.wikidata.org/entity/Q36405766

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Cisplatin sensitivity mediated ...... miR-155 and the miR-15 family.

@ast

Cisplatin sensitivity mediated ...... miR-155 and the miR-15 family.

@en

type

label

Cisplatin sensitivity mediated ...... miR-155 and the miR-15 family.

@ast

Cisplatin sensitivity mediated ...... miR-155 and the miR-15 family.

@en

prefLabel

Cisplatin sensitivity mediated ...... miR-155 and the miR-15 family.

@ast

Cisplatin sensitivity mediated ...... miR-155 and the miR-15 family.

@en

P1433

Q36405766-E42D483A-64C6-4183-A5AB-26099CDC291A

P1476

Q36405766-CAA1406D-F743-40CC-9806-301B5F84D61D

P2093

Q36405766-1324628C-040C-4E79-93D7-8DF4F1FAF95C

Q36405766-3374E4F9-E50F-4BCB-B718-6298545AF556

Q36405766-587EBBBB-B4EA-416C-B385-2238C9511D4B

Q36405766-7D35BA1D-2074-4F84-ACC2-46E07E9B8C9E

Q36405766-86632065-6BD2-4EAB-9A60-58D1060BC903

Q36405766-872F989C-64C3-405B-B59C-CF607AA07E01

Q36405766-AB05F65A-38FF-4A87-AB2A-488B3491DE27

P2860

Q36405766-04D7A089-1185-454F-B955-0D7981A1C300

Q36405766-0EEAB3BE-1A0C-4BA6-A70D-D26118D54395

Q36405766-1550C2AE-B378-4191-BDDE-1B153CA68665

Q36405766-1D1A116D-988F-4EDE-9A16-530EDC6AF681

Q36405766-35D8E888-1BDB-4009-B446-F0DC0874A0D5

Q36405766-3A6F9C6F-6CB8-49F2-93F9-4D81ECC7E1CA

Q36405766-420A37C1-E17C-4AAC-A20E-FDF9EDF504DB

Q36405766-4A559CF0-7DAA-4A04-ADF1-95DB4E468E82

Q36405766-4E0DD907-0BDB-4099-98DB-6BFBBB070161

Q36405766-5758ABDB-63D2-4E54-A1EA-4A6E4BF8356A

P304

Q36405766-7C80EE2C-0BDA-454B-A645-6085928ACE87

P31

Q36405766-3DBB1305-B621-460D-BA6C-E441A23A9E2A

P356

Q36405766-131667BC-7B8B-4359-B24F-335AA9B1D8F5

P407

Q36405766-F31A4DB7-2151-4A7D-BE71-42E3297DED74

P433

Q36405766-38B05C6B-CBBE-4379-88F8-9FAC8CB2A94A

P478

Q36405766-11D7D008-F050-4084-A4EA-C3D4C11E860A

P577

Q36405766-35804FE9-2F82-457A-A51B-36F6E910690E

P698

Q36405766-1AA5F315-302D-49E5-98BF-6EB28D012094

P932

Q36405766-376052D7-212B-472A-86CF-ED82CA146BA2

P356

0008-5472.CAN-12-1400

P1433

Cancer Research

P1476

Cisplatin sensitivity mediated ...... miR-155 and the miR-15 family.

@en

P2093

Jennifer Bai

http://www.w3.org/2001/XMLSchema#string

Lynn M Pouliot

http://www.w3.org/2001/XMLSchema#string

Matthew D Hall

http://www.w3.org/2001/XMLSchema#string

Michael M Gottesman

http://www.w3.org/2001/XMLSchema#string

Rajarshi Guha

http://www.w3.org/2001/XMLSchema#string

Scott E Martin

http://www.w3.org/2001/XMLSchema#string

Yu-Chi Chen

http://www.w3.org/2001/XMLSchema#string

P2860

miR-15 and miR-16 induce apoptosis by targeting BCL2

The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases

MicroRNAs: target recognition and regulatory functions

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

Causes and consequences of microRNA dysregulation in cancer

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

microRNA functions

Targeting cancer with small molecule kinase inhibitors

P304

5945-5955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-12-1400

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22942255

http://www.w3.org/2001/XMLSchema#string

P932

3500396

http://www.w3.org/2001/XMLSchema#string